Abstract
This case-control study examined the potential for a common etiology of Parkinson’s disease (PD) and Alzheimer’s disease (AD) using reported family history. Structured interviews were used to collect AD and PD family history from subjects (n = 1531) with AD, PD, AD/PD, or controls. Intergroup analysis compared reported AD and PD family histories in the three case groups to the histories reported in the control group. Intragroup analysis stratified each diagnostic group based on positive family history of AD, then compared the subgroups for a family history of PD. Subjects with AD had a higher risk of having a family history of AD [odds ratio (OR) 2.3; 1.5–3.4] and subjects with PD had a higher risk of having a family history of PD (OR 2.2; 1.2–4.0) as compared to control subjects. Intergroup analyses revealed no significant crossed risk, increased risk of subjects with AD having a family history of PD vs controls and vice versa. Intragroup analysis found that subjects with PD and a family history of AD were more likely to have a family history of PD (OR 1.7; 1.1–2.6) when compared to subjects with PD and no family history of AD. A similar trend was found for subjects with AD (OR 1.7; 0.9–3.1). AD and PD cases each have an increased familial risk of their respective disease. Probands with AD or PD and a family history of either disease have a higher crossed risk of a family history of the other disease. These findings suggest the existence of common genetic and/or environmental factors that predispose to both AD and PD in the subset of cases with positive family history of both neurodegenerative diseases.
Similar content being viewed by others
References
Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259
Gasser T, Muller-Myhsok B, Wszolek ZK et al (1998) A susceptibility locus for Parkinson’s disease maps to chromosome 2p13. Nat Genet 18:262–265
Goate A, Chartier-Harlin MC, Mullan M et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706
Kitada T, Asakawa S, Hattori N et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605–608
Levy-Lahad E, Wasco W, Poorkaj P et al (1995) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269:973–977
Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047
Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375:754–760
Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977–1981
Valente EM, Bentivoglio AR, Dixon PH et al (2001) Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 68:895–900
Aarsland D, Andersen K, Larsen JP et al (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392
Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486
Boller F, Mizutani T, Roessmann U et al (1980) Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 7:329–335
Hakim AM, Mathieson G (1979) Dementia in Parkinson disease: a neuropathologic study. Neurology 29:1209–1214
Hughes AJ, Daniel SE, Blankson S et al (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50:140–148
Samuel W, Galasko D, Masliah E et al (1996) Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer’s disease. J Neuropathol Exp Neurol 55:44–52
Lippa CF, Smith TW, Nee L et al (1995) Familial Alzheimer’s disease and cortical Lewy bodies: is there a genetic susceptibility factor. Dementia 6:191–194
Aarsland D, Perry R, Brown A et al (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776
Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152:879–884
Fratiglioni L, Ahlbom A, Viitanen M et al (1993) Risk factors for late-onset Alzheimer’s disease: a population-based, case-control study. Ann Neurol 33:258–266
Huff FJ, Auerbach J, Chakravarti A et al (1988) Risk of dementia in relatives of patients with Alzheimer’s disease. Neurology 38:786–790
Silverman JM, Raiford K, Edland S et al (1994) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer’s disease probands and nondemented spouse controls. Neurology 44:1253–1259
Hofman A, Schulte W, Tanja TA et al (1989) History of dementia and Parkinson’s disease in 1st-degree relatives of patients with Alzheimer’s disease. Neurology 39:1589–1592
van Duijn CM, Clayton D, Chandra V et al (1991) Familial aggregation of Alzheimer’s disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20(Suppl 2):S13–S20
Van Duijn CM, Clayton DG, Chandra V et al (1994) Interaction between genetic and environmental risk factors for Alzheimer’s disease: a reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 11:539–551
McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944
Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32(Suppl):S125–S127
Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752
Farrer LA, O’Sullivan DM, Cupples LA et al (1989) Assessment of genetic risk for Alzheimer’s disease among first-degree relatives. Ann Neurol 25:485–493
Sellbach AN, Boyle RS, Silburn PA et al (2006) Parkinson’s disease and family history. Parkinsonism Relat Disord 12:399–409
Devi G, Ottman R, Tang MX et al (2000) Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Arch Neurol 57:72–77
Marder K, Levy G, Louis ED et al (2003) Familial aggregation of early- and late-onset Parkinson’s disease. Ann Neurol 54:507–513
Payami H, Zareparsi S, James D et al (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59:848–850
Sveinbjornsdottir S, Hicks AA, Jonsson T et al (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343:1765–1770
Mickel SF, Broste SK, Hiner BC (1997) Lack of overlap in genetic risks for Alzheimer’s disease and Parkinson’s disease. Neurology 48:942–949
Levy G, Louis ED, Mejia-Santana H et al (2004) Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol 61:1033–1039
Elbaz A, McDonnell SK, Maraganore DM et al (2003) Validity of family history data on PD: evidence for a family information bias. Neurology 61:11–17
Li G, Aryan M, Silverman JM et al (1997) The validity of the family history method for identifying Alzheimer disease. Arch Neurol 54:634–640
Healy DG, Abou-Sleiman PM, Lees AJ et al (2004) Tau gene and Parkinson’s disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 75:962–965
Myers AJ, Kaleem M, Marlowe L et al (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer’s disease. Hum Mol Genet 14:2399–2404
Acknowledgements
This study was supported by the National Institute of Aging Emory Alzheimer’s Disease Research Center (P50 AG025688), the National Institute of Environmental Health Sciences support for the Emory Collaborative Center for Parkinson’s Disease Environmental Research (U54 ES012068), and Woodruff Health Science Center of Emory University. The authors also thank the patients, families, and other participants in the research registries and the staff of the Emory Department of Neurology and Emory Alzheimer’s Disease Research Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosen, A.R., Steenland, N.K., Hanfelt, J. et al. Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history. Neurogenetics 8, 263–270 (2007). https://doi.org/10.1007/s10048-007-0100-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-007-0100-6